RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Accelerated Approval, surrogate endpoints, registration BTW crispr stick is down to $64 from its high of $200 in Jan 2021. Just sayin' that health technology often takes time to prove itself, particularly if it is innovative and novel. And cell and gene therapy hasn't proved itself because of the complexity of the human immune system, where if one tries to change one thing another unexpected thing happens due to homeostasis. That is why a naturally occurring biological product like ONCY's pelareorep is superior over genetically manipulated agents, because of pelareorep's predictability when administered as a naturally occurring OV in the human body and the expected responses of the human immune system in response to pelareorep when this biologic is administered as an immunotherapy in the treatment of multiple cancers.